Title of article
Pharmacological implications of lengthened in-utero exposure to nevirapine Original Research Article
Author/Authors
GP Taylor، نويسنده , , EGH Lyall، نويسنده , , D Back، نويسنده , , C Ward، نويسنده , , Gareth Tudor Williams، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2000
Pages
2
From page
2134
To page
2135
Abstract
Given as a single dose to the mother during labour, nevirapine can protect the neonate from HIV-1 infection for up to 7 days. However, after maternal nevirapine therapy during pregnancy, neonatal plasma concentrations of nevirapine decline more rapidly, suggesting in-utero liver enzyme induction.
Journal title
The Lancet
Serial Year
2000
Journal title
The Lancet
Record number
552185
Link To Document